市場調査レポート

商品コード

1747611

バイオ医薬品CMOおよびCRO市場：原料別、サービス別、製品別、地域別

Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography

出版日: 2025年05月21日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 657,360円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,022,560円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,460,800円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオ医薬品CMOおよびCRO市場は、2025年には406億米ドルと推定され、2032年には606億5,000万米ドルに達すると予測され、2025年から2032年までのCAGRは5.9%です。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	406億米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	5.90%	2032年の価値予測	606億5,000万米ドル

バイオ医薬品CMO（医薬品製造受託機関）とは、医薬品製造サービスからパッケージングに至るまで、バイオ医薬品分野の他の企業にサービスを提供する受託ベースの企業です。一方、CRO（医薬品開発業務受託機関）とは、バイオ医薬品企業に研究サービスを委託するという形でサポートを提供する企業です。

市場力学：

慢性疾患の増加、創薬開発の増加、生物製剤とバイオシミラーの需要増加、アウトソーシングの増加傾向、研究開発投資の増加、バイオ医薬品産業の急成長は、世界のバイオ医薬品CMOおよびCRO市場の成長を促進すると予想される主な要因です。

例えば、2023年2月、ルナフォアとシロナDxは戦略的提携を発表し、シロナDxはルナフォアの主力製品であるCOMET空間生物学プラットフォームをサービスとして提供する米国初のCRO（医薬品開発業務受託機関）となります。COMETは、シロナDxの研究サービスポートフォリオを補完し、様々な分野の研究者やバイオファーマチームのニーズに対応します。COMETは、様々な分野、研究・医薬品開発のあらゆる段階において、幅広い研究アプリケーションを提供します。

本調査の主な特徴

本レポートは、世界のバイオ医薬品CMOおよびCRO市場を詳細に分析し、2024年を基準年として、2025年から2032年の予測期間における市場規模および年間平均成長率（CAGR%）を提供しています。
また、さまざまなセグメントにおける潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のバイオ医薬品CMOおよびCRO市場の主要企業プロファイルを掲載しています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のバイオ医薬品CMOおよびCRO市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
利害関係者は、世界のバイオ医薬品CMOおよびCRO市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Allphase Clinical Research
AlcheraBio
Alcami
Akos Urgent Care
Agilent
AGC Biologics
Affinity Life Sciences, Inc.
Actimus Bio
ACI Clinical
Accumedix, Inc.
Absorption Systems
A10 Clinical Solutions
Albuquerque Clinical Trials（ACT）
Ajinomoto Bio-Pharma Services
Advanced Clinical Services LLC
ACM Global Laboratories
Accelerated Enrollment Solutions
AbbVie Contract Manufacturing
Advanced BioScience Laboratories
Advanced Clinical Research Institute
Alliance for Clinical Trials in Oncology

第9章セクション

調査手法
出版社について

Product Code: CMI5933

Biopharmaceutical CMO and CRO Market is estimated to be valued at USD 40.6 Bn in 2025 and is expected to reach USD 60.65 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 40.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.90%	2032 Value Projection:	USD 60.65 Bn

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:

This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.

Detailed Segmentation:

Global Biopharmaceutical CMO and CRO Market, By Source:
- Mammalian
- Non-mammalian
Global Biopharmaceutical CMO and CRO Market, By Service:
- Contract Manufacturing
- Contract Research
Global Biopharmaceutical CMO and CRO Market, By Product:
- Biologics
- Biosimilars
Global Biopharmaceutical CMO and CRO Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Allphase Clinical Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AlcheraBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alcami
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Akos Urgent Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Affinity Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actimus Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ACI Clinical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Accumedix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Absorption Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
A10 Clinical Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Albuquerque Clinical Trials (ACT)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Clinical Services LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ACM Global Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Accelerated Enrollment Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Contract Manufacturing
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced BioScience Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Clinical Research Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alliance for Clinical Trials in Oncology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

バイオ医薬品CMOおよびCRO市場：原料別、サービス別、製品別、地域別

Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography

市場力学：

本調査の主な特徴

目次：

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のバイオ医薬品CMOおよびCRO市場、原料別、2020年～2032年

第5章世界のバイオ医薬品CMOおよびCRO市場、サービス別、2020年～2032年

第6章世界のバイオ医薬品CMOおよびCRO市場、製品別、2020年～2032年

第7章世界のバイオ医薬品CMOおよびCRO市場、地域別、2020年～2032年

第8章競合情勢

第9章セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Biopharmaceutical CMO and CRO Market, By Source, 2020-2032, (US$ Bn)

5. Global Biopharmaceutical CMO and CRO Market, By Service, 2020-2032, (US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)

8. Competitive Landscape

9. Section

バイオ医薬品CMOおよびCRO市場：原料別、サービス別、製品別、地域別

Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography

市場力学：

本調査の主な特徴

目次：

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界のバイオ医薬品CMOおよびCRO市場、原料別、2020年～2032年

第5章 世界のバイオ医薬品CMOおよびCRO市場、サービス別、2020年～2032年

第6章 世界のバイオ医薬品CMOおよびCRO市場、製品別、2020年～2032年

第7章 世界のバイオ医薬品CMOおよびCRO市場、地域別、2020年～2032年

第8章 競合情勢

第9章 セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Biopharmaceutical CMO and CRO Market, By Source, 2020-2032, (US$ Bn)

5. Global Biopharmaceutical CMO and CRO Market, By Service, 2020-2032, (US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)

8. Competitive Landscape

9. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のバイオ医薬品CMOおよびCRO市場、原料別、2020年～2032年

第5章世界のバイオ医薬品CMOおよびCRO市場、サービス別、2020年～2032年

第6章世界のバイオ医薬品CMOおよびCRO市場、製品別、2020年～2032年

第7章世界のバイオ医薬品CMOおよびCRO市場、地域別、2020年～2032年

第8章競合情勢

第9章セクション